$BNB Windtree Therapeutics announces the raising of $520 million for the purchase of $BNB for its treasury.

This announcement follows the planned purchase of $200 million for $BNB and a partnership with the Kraken exchange for storage.

"Pending shareholder approval, the ability to obtain additional funds for the purchase of more BNB is critical to our strategy"

- Jed Latkin, CEO of Windtree.